Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes

J Infect Dis. 2001 Feb 1;183(3):417-24. doi: 10.1086/318072. Epub 2000 Dec 18.

Abstract

The effect of human immunodeficiency virus type 1 (HIV-1) on telomerase activity in peripheral blood lymphocytes (PBL) was examined. Telomerase is an enzyme that is involved in mechanisms that control cell life span and replicative potential. HIV-1 reduced telomerase activity in in vitro-infected PBL and impaired enzyme activation upon cell stimulation. Telomerase activity was significantly lower in PBL from 23 HIV-1-infected patients than in PBL from healthy donors and significantly increased during highly active antiretroviral therapy (HAART) in 10 patients who had both a virological and an immunological response and in 5 and 8 patients with a virological or an immunological response, respectively. Further analyses of fractionated cells revealed that telomerase activity increased mainly in CD4(+) lymphocytes. Overall, these findings demonstrate that HIV-1 infection down-modulates telomerase activity and suggest that both the HIV-1 decline and immunorestoration in response to HAART contribute to increased telomerase activity in CD4(+) lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • CD4-Positive T-Lymphocytes / enzymology*
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology
  • Cells, Cultured
  • Enzyme Activation
  • HIV Infections / drug therapy
  • HIV Infections / enzymology*
  • HIV Infections / immunology
  • HIV Infections / virology*
  • HIV-1 / physiology*
  • Humans
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / enzymology*
  • Leukocytes, Mononuclear / virology*
  • Lymphocyte Activation
  • Phytohemagglutinins / pharmacology
  • RNA, Viral / blood
  • Telomerase / metabolism*

Substances

  • Phytohemagglutinins
  • RNA, Viral
  • Telomerase